We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment (METILDA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01995344
Recruitment Status : Unknown
Verified November 2013 by Professor Robert Hawkins, University of Manchester.
Recruitment status was:  Not yet recruiting
First Posted : November 26, 2013
Last Update Posted : November 26, 2013
National Institute for Health Research, United Kingdom
Information provided by (Responsible Party):
Professor Robert Hawkins, University of Manchester

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : October 2018
Estimated Study Completion Date : December 2018